Home › Colon Cancer › California › Orange
Colon Cancer clinical trials in Orange, CA
5 studies for Colon Cancer are looking for participants at sites in and around Orange (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- UC IRVINE Health, Orange
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RecruitingPhase 2/3
- Saint Joseph Hospital - Orange, Orange
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecruitingPhase 1/2
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
RecruitingPhase 1
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Orange
Colon Cancer trials in other cities
- Boston, MA22 studies
- New York City, NY22 studies
- Houston, TX20 studies
- Los Angeles, CA16 studies
- Nashville, TN16 studies
- Arlington, VA15 studies
- St. Louis, MO15 studies
- Chicago, IL14 studies
- Baldwin Park, CA14 studies
- San Antonio, TX14 studies
- Tampa, FL13 studies
- Baltimore, MD13 studies
Other studies in Orange
- Non-Small Cell Lung Cancer25 studies
- Metastatic Cancer20 studies
- Colorectal Cancer16 studies
- Ovarian Cancer16 studies
- Pancreatic Cancer15 studies
- Breast Cancer14 studies
- Lung Cancer14 studies
- Prostate Cancer14 studies
- Liver Cancer (Hepatocellular Carcinoma)14 studies
- Melanoma14 studies
- Acute Myeloid Leukemia13 studies
- Cancer (all types)13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.